4 comments

[ 4.0 ms ] story [ 15.8 ms ] thread
"Following a nine-hour evidence session, the FDA advisory committee, composed of mental health and medical experts, voted by a margin of 9 to 2 that the available data did not prove that the drug was an effective treatment of PTSD in combination with therapy. In a second vote, the panel also concluded the benefits of the treatment did not outweigh the risks, with the vote carried by 10 to 1."
Alternative headline: Panel advising US FDA decides PTSD sufferers should enter illegal narcotics market.